OpenURL Connection Search

Select item for more details and to access through your institution.

TGF-β signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE.
Published in:
European Journal of Immunology, 2011, v. 41, n. 10, p. 2987, doi. 10.1002/eji.201141666
By:
- Huss, David J.;
- Winger, Ryan C.;
- Cox, Gina Mavrikis;
- Guerau-de-Arellano, Mireia;
- Yang, Yuhong;
- Racke, Michael K.;
- Lovett-Racke, Amy E.
Publication type:
Article
Your nose knows how to target brain inflammation.
Published in:
2016
By:
- Winger, Ryan C.;
- Zamvil, Scott S.
Publication type:
journal article
The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod.
Published in:
Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 1, p. 1, doi. 10.1177/2055217318819245
By:
- Cohen, Jeffrey A.;
- Bar-Or, Amit;
- Cree, Bruce A. C.;
- Mao-Draayer, Yang;
- Han, May H.;
- Singer, Barry;
- Jannu, Ann;
- Kolodny, Scott;
- Meng, Xiangyi;
- Winger, Ryan C.
Publication type:
Article
Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination.
Published in:
Annals of Clinical & Translational Neurology, 2024, v. 11, n. 7, p. 1750, doi. 10.1002/acn3.52081
By:
- Kister, Ilya;
- Curtin, Ryan;
- Piquet, Amanda L.;
- Borko, Tyler;
- Pei, Jinglan;
- Banbury, Barbara L;
- Bacon, Tamar E.;
- Kim, Angie;
- Tuen, Michael;
- Velmurugu, Yogambigai;
- Nyovanie, Samantha;
- Selva, Sean;
- Samanovic, Marie I.;
- Mulligan, Mark J.;
- Patskovsky, Yury;
- Priest, Jessica;
- Cabatingan, Mark;
- Winger, Ryan C.;
- Krogsgaard, Michelle;
- Silverman, Gregg J.
Publication type:
Article
Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis.
Published in:
Annals of Clinical & Translational Neurology, 2023, v. 10, n. 4, p. 579, doi. 10.1002/acn3.51745
By:
- Barrera, Britney;
- Simpson, Haley;
- Engebretson, Eric;
- Sillau, Stefan;
- Valdez, Brooke;
- Parra‐González, José;
- Winger, Ryan C.;
- Epperson, Lou Anne;
- Banks, Ashley;
- Pierce, Kathryn;
- Spotts, Melanie;
- O'Gean, Katie;
- Alvarez, Enrique;
- Gross, Robert;
- Piquet, Amanda L.;
- Schreiner, Teri;
- Corboy, John R.;
- Pei, Jinglan;
- Vollmer, Timothy L.;
- Nair, Kavita V.
Publication type:
Article
Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies.
Published in:
Annals of Clinical & Translational Neurology, 2022, v. 9, n. 10, p. 1643, doi. 10.1002/acn3.51664
By:
- Kister, Ilya;
- Curtin, Ryan;
- Pei, Jinglan;
- Perdomo, Katherine;
- Bacon, Tamar E.;
- Voloshyna, Iryna;
- Kim, Joseph;
- Tardio, Ethan;
- Velmurugu, Yogambigai;
- Nyovanie, Samantha;
- Valeria Calderon, Andrea;
- Dibba, Fatoumatta;
- Stanzin, Igda;
- Samanovic, Marie I.;
- Raut, Pranil;
- Raposo, Catarina;
- Priest, Jessica;
- Cabatingan, Mark;
- Winger, Ryan C.;
- Mulligan, Mark J.
Publication type:
Article

Found: 6

TGF-β signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE.

Your nose knows how to target brain inflammation.

The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod.

Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination.

Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis.

Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies.